On July 10, 2020, New Horizon Health, a star enterprise in GDMV, announced the completion of a US$30 million Series E financing. The investment was led by Rock Springs Capital, followed by Aobo Capital, Lilly Asia Ventures, Cormorant Asset Management, China Resources Holdings, Octagon Capital and Qiming Venture Capital. Up to now,New Horizon Health has received continuous attention from world-renowned venture capital, biomedical funds and long-term investment institutions, and has received more than 160 million US dollars in investment.